Case-Based Roundtables on TargetedOnc.com are collaborative, small-group discussions about case-based clinical profiles and engaging peer-dialogue led by an expert physician. These resources offer practicing oncologists and hematologists insight on relevant data, treatment strategies, and varying professional opinions.

LATEST CONTENT

Considering the Role of Tivozanib After Prior ICI-Based Therapy in RCC

Neoadjuvant T-DXd Clouds Residual Disease Decisions in HER2+ Breast Cancer

Insurance Hurdles Complicate Febrile Neutropenia Prevention in ES-SCLC

How Disease Burden Shapes First-Line RCC Treatment Selection

Adding Quality of Life to Treatment Goals in Immune Thrombocytopenia

Costa Explains What Drives Survival Benefit With Tec/Dara in Myeloma

Risk, Histology, and Metastatic Site Guide First-Line RCC Treatment Choices

Evaluating Platelet- vs Immune-Directed Therapies in Immune Thrombocytopenia

CASE-BASED ROUNDTABLES

Emerging Multiple Myeloma Therapies and Sequencing Decisions

October 01, 2026

Targeting CSF1 Receptor to Manage Tenosynovial Giant Cell Tumor

September 01, 2026

Sequencing Therapeutics for Severe and Chronic Immune Thrombocytopenia

Selecting Targeted Therapy for Advanced ROS1+ NSCLC

Targeted Inhibition for Grade 2 IDH-Mutant Glioma

December 01, 2025

Small Cell Lung Cancer Treated in Second Line and Later

September 19, 2025

Maintenance Options in Patients With Bladder Cancer

September 16, 2025

Treating First-Line HCC With Immune Checkpoint Inhibition

September 15, 2025

Using Tyrosine Kinase Inhibition in Neuroendocrine Tumors

August 28, 2025

Therapies Reducing Adverse Events in Extensive-Stage SCLC

August 12, 2025

Combination Chemotherapy in Patients With Pancreatic Cancer

Treating With CAR T-Cell Therapy in Second-Line B-Cell Lymphoma

Later-Line Therapies Used in Unresectable or Metastic Melanoma

Multigene Expression Testing in Early-Stage Breast Cancer Management

Patients With Polycythemia Vera Eligible for Treatment Injection

February 27, 2025